| |
Age
|
Gender
|
D
|
HD dur.
|
Fontaine stage
|
VascuQOL First LDL-A
|
VascuQOL Tenth LDL-A
|
VascuQOL One month
|
|---|
|
M
|
|---|
|
Non-CLI
|
68
|
Male
|
(−)
|
21
|
II
|
4.24
|
4.12
|
2.36
|
|
66
|
Male
|
(+)
|
14
|
II
|
5.36
|
5.28
|
5.44
|
|
74
|
Male
|
(+)
|
4
|
II
|
5.68
|
6.24
|
6.24
|
|
74
|
Male
|
(+)
|
6
|
II
|
5.44
|
5.6
|
5.84
|
|
73
|
Male
|
(+)
|
7
|
II
|
3.88
|
4
|
4
|
|
80
|
Male
|
(−)
|
5
|
II
|
2.36
|
2.88
|
2.56
|
|
51
|
Male
|
(−)
|
9
|
II
|
4.72
|
4.48
|
5.48
|
|
70
|
Male
|
(+)
|
1
|
II
|
5.72
|
5.88
|
5.36
|
|
73
|
Male
|
(+)
|
7
|
II
|
5.56
|
6.04
|
5.76
|
|
63
|
Male
|
(+)
|
20
|
II
|
1.64
|
3.04
|
2.96
|
|
68
|
Female
|
(+)
|
12
|
II
|
4.6
|
5.36
|
5.52
|
|
68
|
Male
|
(+)
|
1
|
II
|
5.92
|
5.4
|
5.48
|
|
78
|
Male
|
(−)
|
22
|
II
|
5.84
|
5.88
|
5.44
|
|
70
|
Male
|
(+)
|
1
|
II
|
6.04
|
6.24
|
6.48
|
|
CLI
|
76
|
Male
|
(+)
|
2
|
III
|
2.68
|
2.92
|
3.28
|
|
57
|
Male
|
(+)
|
7
|
IV
|
2.64
|
4.6
|
4.16
|
|
67
|
Male
|
(+)
|
12
|
III
|
3.36
|
2.52
|
3.64
|
|
72
|
Female
|
(+)
|
9
|
III
|
1.92
|
1.8
|
2.84
|
|
81
|
Male
|
(+)
|
1
|
III
|
2.24
|
3.04
|
3.72
|
|
67
|
Female
|
(+)
|
16
|
III
|
3.36
|
3.48
|
3.64
|
|
70
|
Male
|
(+)
|
21
|
IV
|
6.04
|
6.64
|
6.76
|
|
64
|
Female
|
(+)
|
1
|
IV
|
5.28
|
4.76
|
5.16
|
-
HD dur. HD duration (years). One month 1 month after completion of LDL-A treatment
